Table 1. Patients’ characteristics... | American Society of Hematology

Table 1.

Patients’ characteristics

Characteristic	Patients (N = 30)
Characteristic	n	%
Median age, y (range)	29 (21-77)
Age 45-60	4	13.3
Age >60	4 (67-77)	13.3
Sex
Male	11	36.7
Female	19	63.3
Disease stage
IIA	6	20.0
IIB	6	20.0
IIB with >10 cm mass	5	16.7
IIIA	4	13.3
IIIB	1	3.3
IVA	6	20.0
IVB	7	23.3
IPS Score*
0-1	4	13.3
2	6	20.0
3	6	20.0
≥4	2	6.7
ESR >50†	6	50
B symptoms	14	46.7
Extranodal disease	16	53.3
Bone‡	14	46.7
Lung‡	3	10.0
Bulky
>7 cm†	11	91.7
>10 cm	10	33.3
MMR >1/3	9	30.0
>10 cm or MMR >1/3	12	40.0

Characteristic	Patients (N = 30)
Characteristic	n	%
Median age, y (range)	29 (21-77)
Age 45-60	4	13.3
Age >60	4 (67-77)	13.3
Sex
Male	11	36.7
Female	19	63.3
Disease stage
IIA	6	20.0
IIB	6	20.0
IIB with >10 cm mass	5	16.7
IIIA	4	13.3
IIIB	1	3.3
IVA	6	20.0
IVB	7	23.3
IPS Score*
0-1	4	13.3
2	6	20.0
3	6	20.0
≥4	2	6.7
ESR >50†	6	50
B symptoms	14	46.7
Extranodal disease	16	53.3
Bone‡	14	46.7
Lung‡	3	10.0
Bulky
>7 cm†	11	91.7
>10 cm	10	33.3
MMR >1/3	9	30.0
>10 cm or MMR >1/3	12	40.0

IPS, International Prognostic Score; ESR, erythrocyte sedimentation rate, MMR, maximum mediastinal ratio.

Advanced stage patients only (n = 18).

Early-stage patients only (n = 12).

Direct extension to bone in 2 cases (stages IIAE and IIIAE) and to lung in 1 case (stage IIBE).